The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2019 | Spotlight audit on molecular testing in lung cancer
Speaking from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland, Neal Navani, MA, MRCP, MSc, PhD, of the Care Quality Improvement Department, Royal College of Physicians, London, UK, discusses non-small cell lung cancer (NSCLC) tissue sampling and molecular diagnostics. With more biomarkers emerging, comprehensive testing is becoming increasingly important and more complex. Dr Navani highlights how a lack of standard guidelines for sample collection and testing have slowed down the care pathway, and discusses the National Lung Cancer Audit (NLCA) spotlight audit on molecular testing in patients diagnosed with advanced NSCLC.
